Benefits of Extended Anticoagulation May Not Last
New study suggests that oral anticoagulant meds may be needed for the very long term
Rituximab Retreatment at Clinical Relapse Cost-Effective in RA
At least as cost-effective as more intensive regimen in patients with longstanding RA
FDA Approves Entresto for Heart Failure
Medication helps reduce the rate of cardiovascular death, hospitalization
HIV-Infected Patients Frequently Have Chronic Pain
Patients with moderate-severe chronic pain more likely to take antidepressants, prescription opioids
PCV13 Predicted to Be Cost Saving Versus PCV7
Although 13-valent pneumococcal vaccine is more costly than PCV7, net cost savings expected
Researchers ID Patients More Prone to Long-Term Opioid Use
People with a history of smoking or abusing drugs at highest risk of long-term use
Health Insurance Expansion Likely to Increase HTN Treatment
Increase expected to lead to fewer coronary heart disease events, stroke events, CVD-related deaths
Adapted Diabetes Prevention Program Deemed Effective
Older adults more compliant, but significant outcomes improved across ages
Split-Dose Better Than Day-Before Colonoscopy Prep
Patients also prefer split-dose regimens for bowel cleansing
Oxybutynin Deemed Effective Treatment for Hyperhidrosis
Improvement in Hyperhidrosis Disease Severity Scale, quality of life; side effects frequent but minor
